NETAG issues updated recommendation on dexamethasone intravitreal implant (Ozurdex®) in uveitis

Source: NETAG
Area: Evidence > Drug Specific Reviews
The NHS North East Treatment Advisory Group (NETAG) has issued an updated recommendation supporting the use of Ozurdex® (dexamethasone intravitreal implant) for uveitis, only in accordance with the defined treatment protocol from the North East Retinal Group, which would ensure its safe and cost-effective use.

Full Story →